IM Cannabis Secures Another Highly Dilutive Convertible Note and Warrants for $225K

summarizeSummary

IM Cannabis Corp. closed a US$225,000 convertible note and warrant financing, receiving US$202,500 in net proceeds under highly dilutive terms, providing essential short-term capital amidst ongoing financial distress.

check_boxKey Events · Financing and Capital Events · IMCC

• New Convertible Note and Warrants

  IM Cannabis Corp. closed a US$225,000 convertible note financing, receiving US$202,500 in net proceeds, coupled with warrants to purchase 1,483,386 common shares at C$0.22.

• Highly Dilutive Terms

  The convertible note features a variable conversion price, set at the lower of US$0.152 or 90% of the 20-day VWAP, with a floor of US$0.0303, indicating significant potential dilution for existing shareholders.

• Context of Financial Distress

  This financing follows a series of similar dilutive capital raises and a recent 'going concern' warning, highlighting the company's urgent need for capital to sustain operations.

• Support for Operations Amidst Strategic Review

  The proceeds are designated for general corporate purposes, providing short-term liquidity as the company pursues a non-binding letter of intent to sell its European operations.

auto_awesomeAnalysis · IMCC · Life Sciences

IM Cannabis Corp. has secured a US$225,000 convertible note and warrants, providing US$202,500 in net proceeds. This financing is critical for the company's short-term liquidity, especially given its recent 'going concern' warning and Nasdaq bid price non-compliance. However, the terms are highly dilutive, featuring a variable conversion price that can drop to a US$0.0303 floor and significant warrant coverage. This continues a pattern of costly capital raises, reflecting the company's urgent need for funds amidst ongoing financial distress and while it pursues a potential divestiture of its European operations.